Takahashi receives 1 M JPY funding from Okayama University Innovation Management Core for the proposal of “drug discovery innovation by human organ-on-a-chip disease model”
Promoting the development of disruptive innovation “organ-on-a-chip” technology that contributes to the development of drugs that are effective in humans without sacrificing experimental animals
Dr. Ken Takahashi, research associate professor of Department of Cardiovascular Physiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, was selected for Okayama University’s Innovation Management Core Venture Support Field in 2022, and received 1 million Japanese yen for business promotion expenses.
Dr. Takahashi has so far received 33.74 million yen in research funding from the Japan Society for the Promotion of Science and other organizations for his research on organ-on-a-chip technology. The funds raised this time will be used for academic presentations at related academic societies and for the purchase of items necessary for research, in order to realize a licensing business that applies organ-on-a-chip technology and a contract analysis business for pharmacology and toxicity testing of drugs. Dr. Takahashi will promote the development of human organ-on-a-chip, a platform for efficiently developing drugs effective for humans without sacrificing experimental animals such as mice and dogs, and promote pharmaceutical innovation that will change the course of medical history.